Lista de obras -

A call to strengthen the global strategy for schistosomiasis and soil-transmitted helminthiasis: the time is now

artículo científico publicado en 2016

A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni

artículo científico publicado en 2013

A schistosomiasis research agenda

artículo científico publicado en 2007

Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection.

artículo científico publicado en 2015

Adoptive suppression of granuloma formation ⬇️

artículo científico publicado el 1 de marzo de 1976

Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide

artículo científico publicado el 1 de agosto de 1979

Analysis of Anti-Trypanosoma cruzi Antibody Isotype Specificities by Western Blot in Sera from Patients with Different Forms of Chagas' Disease

artículo científico publicado el 1 de junio de 1998

Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni

artículo científico publicado en 2009

Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty

artículo científico publicado en 2017

Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections-Improvement and Use during SCORE

scientific article published on 12 May 2020

Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments

artículo científico publicado en 2009

Comparison of Schistosoma mansoni Prevalence and Intensity of Infection, as Determined by the Circulating Cathodic Antigen Urine Assay or by the Kato-Katz Fecal Assay: A Systematic Review

artículo científico publicado en 2016

Comparison of whole blood cultures and peripheral blood mononuclear cell cultures for evaluation of lymphocyte reactivity during chronic schistosomiasis ⬇️

artículo científico publicado el 1 de enero de 1981

Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research

scientific article published on 12 May 2020

Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans

artículo científico publicado en 2006

Countrywide Reassessment of Schistosoma mansoni Infection in Burundi Using a Urine-Circulating Cathodic Antigen Rapid Test: Informing the National Control Program.

scientific article published on 23 January 2017

Cross‐reactive idiotypes on rabbit anti‐SEA antibodies stimulate anti‐idiotype spleen and lymph node cell responses of mice infected with Schistosoma mansoni ⬇️

artículo científico publicado el 1 de enero de 1996

Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.

artículo científico publicado en 2017

Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies

artículo científico publicado en 2020

Dr. Adel A. F. Mahmoud

artículo científico publicado en 2018

Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.

artículo científico publicado en 2018

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel

artículo científico publicado en 2020

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya ⬇️

artículo científico publicado en 2020

Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections

scientific article published on 12 May 2020

Expression of Major Histocompatibility Complex Antigens and Adhesion Molecules in Hearts of Patients with Chronic Chagas' Disease

artículo científico publicado el 1 de agosto de 1993

Failure of plasma from human schistosomiasis mansoni patients to protect mice from Schistosoma mansoni cercarial challenge

artículo científico publicado el 1 de julio de 1977

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the

scientific article published on 01 December 2019

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.

artículo científico publicado en 2018

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

artículo científico publicado en 2016

Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications

artículo científico publicado en 2005

Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment.

artículo científico publicado en 2003

Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni

artículo científico publicado en 2006

Historical perspective: Revisiting the St. Lucia Project, a multi-year comparison trial of schistosomiasis control strategies.

artículo científico publicado en 2018

Human schistosomiasis

artículo científico publicado en 2014

Human schistosomiasis mansoni: studies on in vitro granuloma modulation

artículo científico publicado el 1 de enero de 1992

Humoral immune responses in human hepatosplenic schistosomiasis mansoni

artículo científico publicado el 1 de noviembre de 1978

IL‐10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni ⬇️

artículo científico publicado el 1 de agosto de 1997

Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease

artículo científico publicado en 2002

Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae

artículo científico publicado el 1 de enero de 1977

Immune responses during human schistosomiasis mansoni. II. Occurrence of eosinophil-dependent cytotoxic antibodies in relation to intensity and duration of infection

artículo científico publicado el 1 de septiembre de 1977

Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations

artículo científico publicado el 1 de septiembre de 1977

Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A ⬇️

artículo científico publicado el 1 de abril de 1978

Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells ⬇️

artículo científico publicado el 1 de abril de 1979

Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations ⬇️

artículo científico publicado el 1 de abril de 1979

Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis ⬇️

artículo científico publicado el 1 de junio de 1983

Immune responses during human schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates

artículo científico publicado el 1 de abril de 1992

Immunological profiles of patients from endemic areas infected with Schistosoma mansoni

artículo científico publicado el 1 de enero de 1992

Immunology of human schistosomiasis

artículo científico publicado en 2014

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

artículo científico publicado en 2004

Immunoregulation in experimental schistosomiasis: in vitro induction and assay of spleen cell suppressor activity ⬇️

artículo científico publicado el 1 de junio de 1979

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa

scientific article published on 12 May 2020

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study

artículo científico publicado en 2018

Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.

artículo científico publicado en 2018

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

artículo científico publicado en 2009

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-gamma mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spl ⬇️

artículo científico publicado el 1 de abril de 1992

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni

artículo científico publicado en 2010

Infection with Schistosoma mansoni correlates with altered immune responses to Ascaris lumbricoides and hookworm

artículo científico publicado en 2002

Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni

artículo científico publicado en 2010

Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya

artículo científico publicado en 2004

Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.

artículo científico publicado en 2018

Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting

scientific article published on 12 May 2020

Mapping Schistosoma mansoni endemicity in Rwanda: a critical assessment of geographical disparities arising from circulating cathodic antigen versus Kato-Katz diagnostics

artículo científico publicado en 2019

Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania

scientific article published on 01 February 2020

Molecular helminthology: an integrated approach

artículo científico publicado en 2002

Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?

artículo científico publicado en 2014

Multiple Praziquantel Treatments of Schistosoma mansoni Egg-Negative, CCA-Positive Schoolchildren in a Very Low Endemic Setting in Egypt Do Not Consistently Alter CCA Results

scientific article published on 01 June 2019

New Tools for Old Questions: How Strictly Human Are "Human Schistosomes" - And Does It Matter?

artículo científico publicado en 2018

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel

scientific article published on 01 September 2019

Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni.

artículo científico publicado en 2002

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries

artículo científico publicado en 2017

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

artículo científico publicado en 2009

Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study

artículo científico publicado en 2002

SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission

scientific article published on 12 May 2020

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection

scientific article published on 12 May 2020

Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid

artículo científico publicado en 2016

Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice

artículo científico publicado el 1 de septiembre de 1992

Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and Evolution

scientific article published on 12 May 2020

Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?

artículo científico publicado en 2017

Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

artículo científico publicado en 2009

Short report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1.

artículo científico publicado en 2004

Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach

artículo científico publicado en 2012

Survey of Schistosomiasis in Saint Lucia: Evidence for Interruption of Transmission

artículo científico publicado en 2020

T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment

artículo científico publicado en 2007

Test, Treat, Track, Test, and Treat Active Surveillance toward Elimination of Schistosomiasis: A Feasibility Study

artículo científico publicado en 2020

The Schistosomiasis Consortium for Operational Research and Evaluation 2008-2020: Approaches, Experiences, Lessons, and Recommendations

scientific article published on 12 May 2020

The Schistosomiasis Consortium for Operational Research and Evaluation Rapid Answers Project: Systematic Reviews and Meta-Analysis to Provide Policy Recommendations Based on Available Evidence

scientific article published on 12 May 2020

The immunology of schistosomiasis: workshop report IV

artículo científico publicado el 1 de septiembre de 1979

Thirty-Day Daily Comparisons of Kato-Katz and CCA Assays of 45 Egyptian Children in Areas with Very Low Prevalence of

artículo científico publicado en 2019

Time to set the agenda for schistosomiasis elimination

artículo científico publicado en 2012

Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test

scholarly article by Oliver Bärenbold et al published December 2018 in PLoS Neglected Tropical Diseases

Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review

artículo científico publicado en 2011

When Should the Emphasis on Schistosomiasis Control Move to Elimination?

artículo científico publicado en 2018

Workshop report: Schistosomiasis vaccine clinical development and product characteristics.

artículo científico publicado en 2015

Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination

artículo científico publicado en 2018

[Immunological Responses By Soluble Egg Antigen Of Schistosoma Mansoni In Mice]

artículo científico publicado en 1984

Lista de obras de

A call to strengthen the global strategy for schistosomiasis and soil-transmitted helminthiasis: the time is now

A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni

A schistosomiasis research agenda

Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection.

Adoptive suppression of granuloma formation ⬇️

Adoptive suppression of granuloma formation by T lymphocytes and by lymphoid cells sensitive to cyclophosphamide

Analysis of Anti-Trypanosoma cruzi Antibody Isotype Specificities by Western Blot in Sera from Patients with Different Forms of Chagas' Disease

Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni

Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty

Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections-Improvement and Use during SCORE

Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments

Comparison of Schistosoma mansoni Prevalence and Intensity of Infection, as Determined by the Circulating Cathodic Antigen Urine Assay or by the Kato-Katz Fecal Assay: A Systematic Review

Comparison of whole blood cultures and peripheral blood mononuclear cell cultures for evaluation of lymphocyte reactivity during chronic schistosomiasis ⬇️

Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research

Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans

Countrywide Reassessment of Schistosoma mansoni Infection in Burundi Using a Urine-Circulating Cathodic Antigen Rapid Test: Informing the National Control Program.

Cross‐reactive idiotypes on rabbit anti‐SEA antibodies stimulate anti‐idiotype spleen and lymph node cell responses of mice infected with Schistosoma mansoni ⬇️

Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.

Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies

Dr. Adel A. F. Mahmoud

Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel

Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya ⬇️

Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections

Expression of Major Histocompatibility Complex Antigens and Adhesion Molecules in Hearts of Patients with Chronic Chagas' Disease

Failure of plasma from human schistosomiasis mansoni patients to protect mice from Schistosoma mansoni cercarial challenge

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

Genetic differences in Pneumocystis isolates recovered from immunocompetent infants and from adults with AIDS: Epidemiological Implications

Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment.

Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni

Historical perspective: Revisiting the St. Lucia Project, a multi-year comparison trial of schistosomiasis control strategies.

Human schistosomiasis

Human schistosomiasis mansoni: studies on in vitro granuloma modulation

Humoral immune responses in human hepatosplenic schistosomiasis mansoni

IL‐10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni ⬇️

Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease

Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae

Immune responses during human schistosomiasis mansoni. II. Occurrence of eosinophil-dependent cytotoxic antibodies in relation to intensity and duration of infection

Immune responses during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocyte blastogenic responses to schistosome antigen preparations

Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A ⬇️

Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells ⬇️

Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations ⬇️

Immune responses during human schistosomiasis mansoni. X. Production and standardization of an antigen-induced mitogenic activity by peripheral blood mononuclear cells from treated, but not active cases of schistosomiasis ⬇️

Immune responses during human schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates

Immunological profiles of patients from endemic areas infected with Schistosoma mansoni

Immunology of human schistosomiasis

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

Immunoregulation in experimental schistosomiasis: in vitro induction and assay of spleen cell suppressor activity ⬇️

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study

Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-gamma mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spl ⬇️

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni

Infection with Schistosoma mansoni correlates with altered immune responses to Ascaris lumbricoides and hookworm

Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni

Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya

Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.

Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting

Mapping Schistosoma mansoni endemicity in Rwanda: a critical assessment of geographical disparities arising from circulating cathodic antigen versus Kato-Katz diagnostics

Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania

Molecular helminthology: an integrated approach

Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?

Multiple Praziquantel Treatments of Schistosoma mansoni Egg-Negative, CCA-Positive Schoolchildren in a Very Low Endemic Setting in Egypt Do Not Consistently Alter CCA Results

New Tools for Old Questions: How Strictly Human Are "Human Schistosomes" - And Does It Matter?

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel

Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni.

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study

SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection

Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid

Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice

Schistosomiasis Consortium for Operational Research and Evaluation (SCORE): Its Foundations, Development, and Evolution

Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?

Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.